The past few decades have seen dramatic increases in obesity prevalence in all age groups worldwide ([@b35-ehp-119-272]; [@b71-ehp-119-272]). There is substantial evidence that obesity risk may begin very early in life; \> 40 studies have documented rapid weight gain in the first few months after birth to be associated with obesity later in life ([@b1-ehp-119-272]; [@b3-ehp-119-272]; [@b4-ehp-119-272]; [@b7-ehp-119-272]; [@b9-ehp-119-272]; [@b11-ehp-119-272]; [@b13-ehp-119-272]; [@b14-ehp-119-272]; [@b16-ehp-119-272]; [@b20-ehp-119-272]; [@b26-ehp-119-272]; [@b32-ehp-119-272]; [@b33-ehp-119-272]; [@b38-ehp-119-272]; [@b51-ehp-119-272]; [@b50-ehp-119-272]; [@b63-ehp-119-272]; [@b67-ehp-119-272]) or related metabolic disorders ([@b8-ehp-119-272]; [@b17-ehp-119-272]; [@b23-ehp-119-272]; [@b28-ehp-119-272]; [@b40-ehp-119-272]; [@b42-ehp-119-272]). Although feeding practices likely play a role ([@b36-ehp-119-272]; [@b76-ehp-119-272]), there is considerable uncertainty regarding other factors that may program this rapid infant growth.

There is emerging interest in the possibility that perinatal exposure to certain xenobiotic chemicals may be obesogenic ([@b21-ehp-119-272]; [@b25-ehp-119-272]). Substantial evidence suggests that gestational tobacco exposure is related to excess weight gain and later obesity ([@b47-ehp-119-272]; [@b49-ehp-119-272]). Laboratory studies suggest that prenatal exposure to some endocrine-disrupting compounds (EDCs) may also promote obesity. For example, despite similar dietary intakes, excess postnatal weight gain has been observed in mice exposed perinatally to bisphenol A (BPA) or organotins ([@b22-ehp-119-272]; [@b57-ehp-119-272]; [@b60-ehp-119-272]). However, few EDCs have been examined in laboratory studies thus far. More important, there are limited empirical data linking such exposures to obesity in humans ([@b15-ehp-119-272]). One recent study ([@b59-ehp-119-272]) reported an association between obesity at 6.5 years of age and prenatal hexachlorobenzene (HCB) exposure, and two reported fetal exposure to 2,2-bis(*p*-chlorophenyl)-1,1-dichloroethylene (DDE) to be associated with higher body mass index (BMI) at 3 years of age ([@b68-ehp-119-272]) or in adulthood ([@b34-ehp-119-272]). It remains uncertain whether such exposures in humans may program rapid weight gain beginning in infancy.

In this study we examined the relationship between rapid weight gain in the first 6 months of life and prenatal exposure to several organochlorine compounds (OCs) with endocrine-disrupting properties, including DDE and HCB. Because maternal weight status may modify children's risk of obesity, perhaps due to differential feeding practices ([@b5-ehp-119-272]) or higher OC concentrations among those with higher BMIs ([@b31-ehp-119-272]), we examined possible effect modification by prepregnancy overweight/obesity (hereafter overweight) *a priori*. We also examine how rapid early weight gain and OC exposure relate to BMI status attained in the second year of life.

Materials and Methods
=====================

Data come from the Environment and Childhood Project \[Infancia y Medio-Ambiente (INMA)\] in Sabadell (Catalonia, Spain), a population-based birth cohort that enrolled 657 women in 2004--2006, during the first trimester of pregnancy ([@b54-ehp-119-272]). Women were recruited from public health centers during their first ultrasound visit (mean ± SD, 13.5 ± 1.7 weeks' gestation); 99.5% of Spaniards have public health insurance, and an estimated 70--90% of women use public health services during pregnancy ([@b53-ehp-119-272]). The participation rate was 60%. Questionnaires were administered by trained interviewers during the first and third trimester, at delivery, and at 6 and 14 months after birth to assess health and feeding behaviors, health status, sociodemographic characteristics, reproductive history, and other factors. Maternal blood was collected at recruitment. Birth outcomes were available for 616 women (94%), including 599 term births (≥ 37 weeks' gestation) eligible for this analysis. Of these, 518 (86%) had data on infant growth, OCs, and key covariates and were included in the analysis sample. Ethical approval was obtained from the Clinical Research Ethical Committee of the Municipal Institute of Health Care, and informed consent was obtained from all subjects.

Infant anthropometry
--------------------

Infant weight (nearest gram) and length (nearest 0.1 cm) were measured at birth and at 14 months by trained staff in using standard protocols ([@b45-ehp-119-272]). Infants below the 10th percentile of a Spanish reference were classified as small for gestational age (SGA) ([@b6-ehp-119-272]). Repeated measures of infant weight throughout the first 6 months were abstracted from medical records. Weight gain from birth to 6 months was estimated in two ways. First, weight measures were used to construct sex-specific growth curves using mixed models with random intercept and slope after transformations based on fractional polynomials ([@b56-ehp-119-272]). These curves were used to estimate weight at 6 months of age for infants not measured within ±14 days of their exact 6-month anniversary (16.2% of the sample). The correlation between measured and predicted 6-month weight was 0.96; restricting the analysis to infants with measured weights yielded very similar results (data not shown). Second, weight measured within ±1 month of the 6-month anniversary was used to estimate average daily weight gain through 6 months (95.8% of the analysis sample). Defining rapid growth as the highest tertile of average daily weight gain yielded very similar results (data not shown).

To define rapid growth, weight at birth and at 6 months of age was standardized based on the World Health Organization referent ([@b10-ehp-119-272]). Rapid growth was defined as a *z*-score change of \> 0.67 between birth and 6 months of age, and slow growth was defined as a *z*-score change of \< 0.67 ([@b48-ehp-119-272]). Results were consistent with defining rapid growth using internal standardization of the sample or the U.S. Centers for Disease Control and Prevention referent ([@b37-ehp-119-272]) (data not shown). Additionally, to estimate effects of rapid early growth and OC exposure on later nutritional status, we estimated associations with BMI-for-age *z*-scores at 14 months of age. BMI *z*-scores ≥ 1.44, corresponding to the 85th percentile typically used to define child overweight, were defined as elevated. Consistent results were obtained classifying 14-month weight status using the U.S. referent and weight-for-length *z*-scores (data not shown).

OC exposures
------------

Maternal first-trimester serum levels of DDE, HCB, DDT \[2,2-bis(*p*-chlorophenyl)-1,1,1-trichloroethane\], β-hexachlorohexane (βHCH), and polychlorinated biphenyl (PCB) congeners 118, 138, 153, and 180 were measured by the Public Health Laboratory of the Basque government, using methods described elsewhere ([@b19-ehp-119-272]). Because 99% of the sample had DDT levels below the limits of detection (LODs), this OC was excluded from the analysis. All subjects had detectable levels of DDE. For the remaining OCs, with up to approximately 10% below the LODs, levels were adjusted for lipids as prescribed by [@b52-ehp-119-272]. Values below the LOD were imputed as LOD/2.

Other variables
---------------

Maternal age, parity, education level, prepregnancy weight, country of origin, and occupation, along with paternal height, weight, and occupation, were reported by mothers at recruitment. Occupation data were used to assess social class ([@b30-ehp-119-272]). Maternal height (nearest 0.5 cm) was used to calculate prepregnancy BMI (weight in kilograms/height in square meters) to classify women as normal weight, overweight (BMI ≥ 25 kg/m^2^), or obese (≥ 30 kg/m^2^). Weight gains throughout pregnancy from prenatal visit records were used to validate prepregnancy weight and to estimate gestational weight gain adequacy ([@b29-ehp-119-272]). Information on tobacco use throughout pregnancy was self-reported in the first and third trimesters, child sex was recorded at birth, and breast-feeding duration was reported in postnatal questionnaires. All analyses of rapid growth were conducted in the sample with complete data for the main exposure, outcome, and covariates (*n* = 518); analyses of BMI at 14 months had slightly fewer observations because of missing values for this variable (*n* = 502). Within the analysis sample with complete exposure and outcome data, there were few additional missing values for covariates (*n* = 17 and *n* = 16, respectively, for analyses of rapid growth and BMI at 14 months).

Statistical analysis
--------------------

Characteristics of rapid versus average/slow growers, including maternal OC levels and infant anthropometric measures, were described using means ± SD or proportions, with chi-square, analysis of variance, Student's *t*-test, or Wilcoxon--Mann--Whitney tests applied as appropriate to assess statistical significance (*p* \< 0.05 considered significant for main effects). Because maternal weight status was found to modify the effect of OC exposures on rapid growth (*p* \< 0.10 used to define significance for interactions), OC levels were also described separately among normal-weight versus overweight women. Because distributions were skewed, geometric means were used to describe levels of OCs and significance assessed using Wilcoxon--Mann--Whitney tests on log-transformed data. Relationships among OCs were assessed using Spearman's correlations and log-transformed data.

Generalized linear models (GLMs) for binary outcomes were used to estimate relative risks (RRs) and 95% confidence intervals (CIs) for associations between increasing levels of each OC and rapid early growth ([@b78-ehp-119-272]). To assess the linearity of relationships, generalized additive models were used to examine the shape of the dose--response relationship adjusted for relevant confounders ([@b24-ehp-119-272]). When relationships were nonlinear, OC quartiles were used; log-transformed continuous variables were used for linear relationships. GLMs were also used to assess how both rapid early growth and prenatal OCs---separately as well as adjusting simultaneously---related to the risk of elevated BMI at 14 months.

Maternal characteristics (age, education, social class, parity, prepregnancy weight status, gestational weight gain, smoking during pregnancy, weeks of gestation at blood sampling, triglycerides, cholesterol) and other potential influences on postnatal growth, including child's sex, gestational age at birth and SGA status, paternal height and weight, and breast-feeding duration, were considered as potential confounders of associations between prenatal OCs and infant growth. Covariates retained in the final models included infants' exact age at measurement and variables that resulted in a change in estimate ≥ 10%.

In supplementary analyses, we confirmed that excluding SGA (*n* = 28) or low-birth-weight (*n* = 15) infants, among whom catch-up growth may be normative, did not meaningfully change results. Results for individual PCB congeners, similar to those for the sum of PCBs, are not shown. Excluding women born outside Spain (*n* = 50), who may differ in terms of OC exposures and infant care practices, and excluding nonwhite (*n* = 13) or underweight (BMI \< 18; *n* = 30) mothers at the start of pregnancy also had no meaningful influence on results (data not shown).We examined whether child sex modified effects of OCs on growth; interactions did not reach significance (*p* \> 0.10). Finally, we confirmed that associations did not change when meaningfully restricting the referent to average growers (*n* = 276, 53.28% of the sample) rather than average/slow growers (data not shown). All analyses used STATA, version 10.1 (StataCorp LP, College Station, TX, USA).

Results
=======

Though rapid growers weighed less at birth (mean difference, 293 g), by 6 months of age these infants were significantly heavier than were average/slow growers (891 g) ([Table 1](#t1-ehp-119-272){ref-type="table"}). Rapid growers remained taller and heavier at 14 months.

OCs and rapid growth among normal-weight versus overweight mothers
------------------------------------------------------------------

HCB and βHCH were highly correlated (Spearman's *r* = 0.79, log-transformed variables), with more moderate correlations with DDE (HCB--DDE, *r* = 0.29; βHCH--DDE, *r* = 0.39; PCBs--DDE, *r* = 0.39) and PCBs (PCBs--HCB, *r* = 0.51; PCBs--βHCH, *r* = 0.40). Overall, mean levels of all OCs were similar among rapid and average/slow growers ([Table 2](#t2-ehp-119-272){ref-type="table"}). However, among infants of women of normal prepregnancy weight, mean levels of DDE, HCB, and βHCH were significantly higher among rapid growers than among average/slow growers (*p* \< 0.05). Neither the sum of PCBs nor individual PCBs (data not shown) were associated with rapid growth. In contrast, among infants of women overweight before pregnancy, mean OC levels were lower among rapid growers than among average/slow growers, although differences were not statistically significant.

Among infants whose mothers were of normal prepregnancy weight, associations between increasing prenatal DDE exposure and rapid growth were nonlinear, with an increasing predicted risk followed by an apparent decline in the top 3% of exposure \[\> 750 ng/g; \~ 6.6 ng/g on the log scale; see Supplemental Material, Figure 1 (doi:10.1289/ehp.1002169)\]. Therefore, OC exposures were categorized as quartiles to examine dose--response relationships between OCs and rapid growth ([Table 3](#t3-ehp-119-272){ref-type="table"}). Except for PCBs (data not shown), which were essentially unrelated to rapid growth (21.3%/25.2% rapid growers in the top/bottom quartile), risk of rapid growth among infants of normal-weight mothers rose with increasing quartiles of exposure to each OC. Disparities in rapid growth in this group were greatest for DDE, with a nearly 3 times greater frequency (29.8% vs. 11.7%; *p* \< 0.05) in the highest than in the lowest quartiles. After multivariable adjustment, exposures above the lowest quartile of DDE were associated with a 2.4 times greater risk of rapid growth among normal-weight mothers (*p* \< 0.05). Associations were similar and remained significant after adjusting for other OCs. For HCB and βHCH, however, associations with rapid growth were weakened and not significant after adjusting for DDE ([Table 3](#t3-ehp-119-272){ref-type="table"}). Because HCB and βHCH were highly correlated, we examined results adjusting for either OC but not both simultaneously; findings were very similar (data not shown).

In the group of infants with normal-weight mothers, risk of rapid growth associated with the top quartile of DDE exposure was slightly strengthened by excluding the subjects (*n* = 15) with DDE \> 750 ng/g (6.6 ng/g, log scale), none of whom were rapid growers (RR, 2.76; 95% CI, 1.36--5.62). Alternatively, excluding foreign-born mothers (73.3% of subjects at this level of exposure) had little effect (fourth vs. first quartile: RR = 2.35; 95% CI, 1.15--5.01). Results were also consistent after excluding *n* = 28 SGA infants (RR = 2.65; 95% CI, 1.26--5.58), or *n* = 15 low-birth-weight infants (RR = 3.04; 95% CI, 1.45--6.35). Using log DDE as a continuous measure, the RR per one-unit increase (2.72 ng/g on the original scale) was 1.24 (95% CI, 1.02--1.50) for all subjects and was 1.60 (95% CI, 1.22--2.09) after excluding the top 3% of exposure. Compared with infants of normal-weight mothers, infants in the smaller sample with overweight mothers showed associations that were inverse but not significant.

To maximize cell sizes in models stratified by maternal overweight, we used tertiles to explore whether associations between OCs and rapid growth varied by infant sex. Although DDE--child sex interaction terms did not achieve statistical significance (*p* = 0.17 overall; *p* = 0.14 among normal-weight mothers), DDE was more strongly associated with rapid growth in boys than in girls. Among boys with normal-weight mothers, the risk of rapid growth in the intermediate and highest tertiles of DDE was more than three times higher than in the lowest tertile (highest vs. lowest tertile: multivariable-adjusted RR = 3.61; 95% CI, 1.36--9.56; *n* = 6 rapid growers in the referent group). The intermediate (RR = 1.71; 95% CI, 0.90--3.23) but not the highest (RR = 0.90; 95% CI, 0.40--2.08) tertile of DDE was positively, although not significantly, associated with rapid growth in girls (*n* = 13 rapid growers in the referent group).

OCs, rapid growth, and BMI at 14 months
---------------------------------------

At 14 months, 13.9% of infants had elevated BMI *z*-scores. Rapid growers were more likely than were average/slow growers to have an elevated BMI *z*-score (35.5% vs. 7.1%; *p* \< 0.05). After multivariable adjustment, rapid growth in the first 6 months was associated with a 5 times higher risk of elevated 14-month BMI, with similar associations among normal-weight and overweight mothers. In addition, prenatal DDE, but not other OCs, was associated with elevated BMI *z*-scores at 14 months among infants of normal-weight mothers ([Table 4](#t4-ehp-119-272){ref-type="table"}).

Discussion
==========

There is growing awareness that factors aside from increasing intakes of energy-dense foods and declining physical activity may play key roles in the obesity epidemic ([@b46-ehp-119-272]). It is also increasingly apparent that long-term obesity risk may be evident from rapid growth initiated in the first months of life ([@b51-ehp-119-272]). In this study, we found that among mothers not overweight or obese before pregnancy, higher DDE levels in first-trimester serum were strongly associated with two indicators of early obesity risk in their children: rapid weight gain in the first 6 months of life and elevated BMI *z*-scores at 14 months. These results are consistent with two earlier studies that reported associations between prenatal DDE exposure and obesity later in life ([@b34-ehp-119-272]; [@b68-ehp-119-272]). However, this analysis suggests, to our knowledge for the first time, that fetal DDE exposure may promote rapid growth starting in the immediate postnatal period, consistent with the hypothesis that early-life exposure to EDCs may promote obesogenic changes in metabolism ([@b25-ehp-119-272]).

Regardless of DDE exposure levels and maternal prepregnancy weight status, children with rapid growth in the first months of life had a 5 times higher risk of attaining BMIs exceeding the 85th percentile by 14 months of age. Although changes in feeding and other care practices could influence future growth trajectories in these children ([@b33-ehp-119-272]), numerous studies suggest heavier weight status at 1--2 years is predictive of later obesity ([@b2-ehp-119-272]).

The "environmental obesogen" hypothesis postulates that the developmental period is a vulnerable window during which transient environmental exposures may alter the regulation of weight or adiposity over the long term, perhaps as a consequence of epigenetic changes influencing gene expression or protein regulation ([@b25-ehp-119-272]; [@b41-ehp-119-272]). *In vitro* and animal experiments suggest that some EDCs may upregulate adipogenesis or promote fat storage through mechanisms such as the activation of retinoid-X receptor, peroxisome proliferator activated receptor-γ, or glucocorticoid receptor pathways or by disruption of estrogen receptor signaling ([@b21-ehp-119-272]; [@b58-ehp-119-272]). The issue is of concern because exposure to many EDCs is widespread, as a result of long half-lives and extensive use in agriculture and industry ([@b39-ehp-119-272]; [@b75-ehp-119-272]). Despite evidence of obesogenicity for a few chemicals in animal studies, however, few empirical data have linked such exposures to obesity in humans. In cross-sectional studies, higher levels of EDCs such as BPA and phthalates have been reported in obese than in normal-weight subjects, although because these EDCs are fat soluble, it is not clear whether this partly reflects larger adipose tissue depots in fatter subjects ([@b39-ehp-119-272]; [@b62-ehp-119-272]).

DDE, a metabolite of the pesticide DDT, has not been explored in animal studies on environmental obesogens. However, experimental data indicate that DDE does modulate endocrine function and influences gene expression after binding to nuclear receptors ([@b44-ehp-119-272]; [@b61-ehp-119-272]). Although DDT use is prohibited in most industrialized countries, including Spain, high concentrations of DDE continue to be reported in human biomarker studies because of its long half-life and persistence in water, sediments, and the food chain. DDE levels in this sample were similar to those reported both among pregnant women by [@b68-ehp-119-272] and in first-trimester samples in the U.S. National Health and Nutrition Examination Survey ([@b70-ehp-119-272]).

Other than DDE, the OCs examined in this study were not independently associated with either rapid early weight gain or BMI at 14 months. For PCBs, the absence of association is consistent with data from [@b34-ehp-119-272], although [@b68-ehp-119-272] reported a very small increase in BMI *z*-scores associated with PCB exposure (0.003 for each 1-ng/g increase). [@b68-ehp-119-272] reported HCB exposure in a range similar to those in our sample to be unassociated with BMI through 3 years of age. Prenatal HCB levels here were three times lower than in a previous study ([@b59-ehp-119-272]) reporting an association with later childhood obesity (median, 0.25 vs. 0.68 ng/mL). Further research is needed to ascertain whether disparities in exposure levels or different mechanisms of action for either individual OCs or mixtures might explain why we observed significant positive associations only for DDE.

Excluding SGA or low-birth-weight infants had little influence; indeed, results were slightly strengthened after excluding either group. This is important given that rapid early growth was initially thought to increase obesity risk predominantly in SGA infants, who might be programmed *in utero* to use dietary energy efficiently, perhaps increasing susceptibility to excess weight gain when exposed to energy-dense foods and sedentary environments ([@b12-ehp-119-272]). It is now evident, however, that rapid early weight gain is linked with obesity among infants of average size ([@b33-ehp-119-272]; [@b42-ehp-119-272]).

None of the small number of infants at the very highest levels of maternal DDE exposure (\> 750 ng/g), primarily of foreign-born mothers, experienced rapid growth in the first 6 months. We cannot determine whether this occurred by chance, or whether very highly exposed children might be at reduced risk of rapid weight gain. However, similar opposing patterns of risk at low versus high exposure levels have been reported in other studies on health effects of xenoestrogens ([@b69-ehp-119-272]; [@b73-ehp-119-272]). Reasons for the differential associations between fetal DDE exposure and rapid growth by maternal prepregnancy weight status are also uncertain; although the sample was small, associations between DDE and early rapid growth appeared to be negative among overweight mothers. In our study, children of obese mothers were at increased risk of overweight for reasons independent of chemical exposures: these infants had higher weight and BMI *z*-scores at birth and at 6 and 14 months of age regardless of prenatal DDE levels (data not shown). Experimental evidence suggests that offspring of obese mothers may be at increased risk of obesity, possibly due to genetic susceptibility or perhaps to epigenetic changes ([@b72-ehp-119-272]; [@b77-ehp-119-272]). For example, lower intakes of nutrients such as folate, which has been reported among obese pregnant women ([@b55-ehp-119-272]), may increase risk of offspring obesity, given animal studies showing dietary supplementation with methyl donors including folate to be associated with reduced body weight in subsequent generations ([@b72-ehp-119-272]). Animal studies have also reported stronger obesogenic effects of high-fat diets in offspring of obese than of normal-weight mothers ([@b74-ehp-119-272]). Moreover, observational studies have reported breast-feeding to be more strongly protective against child obesity among overweight mothers than among normal-weight mothers ([@b43-ehp-119-272]). Very early growth patterns among infants of overweight and obese mothers may, therefore, be more strongly related to factors other than OC exposure.

Although interactions with child sex did not reach significance either overall or after stratifying by maternal weight status (*p* \> 0.10), associations between DDE and rapid growth were stronger in boys. Some studies have suggested that effects of periconceptional exposures to EDCs and other factors may be sex-specific ([@b18-ehp-119-272]; [@b64-ehp-119-272]). The modest sample size may have lacked power to detect statistically significant interactions.

Although prenatal DDE exposure was associated with rapid weight gain and BMI, no direct measures of adiposity were available. However, previous studies have reported that rapid weight gain was more strongly associated with direct measures of body fatness than with BMI ([@b27-ehp-119-272]; [@b33-ehp-119-272]). We measured prenatal DDE only in maternal serum collected in early pregnancy; levels have been observed to increase later in pregnancy because of metabolic changes during gestation ([@b65-ehp-119-272]; [@b70-ehp-119-272]). However, studies using repeated measures from multiple trimesters have found that only first-trimester DDE was associated with early neurodevelopment and genital structure alterations ([@b65-ehp-119-272], [@b66-ehp-119-272]). Although potential mechanisms are uncertain, associations with first-trimester measures are consistent with hypotheses involving epigenetic changes, because such effects have been observed to be more frequent for periconceptional than for later exposures ([@b41-ehp-119-272]; [@b64-ehp-119-272]). Other limitations include the modest sample size, resulting in few rapid growers in the referent group and fairly wide conference intervals. An important strength is the large number of potential confounders considered, including birth weight and weight gain in pregnancy, which were only weakly (Spearman's *r* \< 0.10) correlated with prenatal DDE and did not confound associations. Although follow-up thus far is short, future analyses will assess longer-term effects of OCs on postnatal growth.

Conclusion
==========

We found that among normal-weight mothers, prenatal DDE exposure was associated with an increased risk of rapid growth in the first 6 months of life, as well as elevated BMI at 14 months. Other OCs examined were not associated with increased risk of rapid growth. Given the large body of evidence indicating that rapid weight gain in the first months of life increases long-term risk of obesity and metabolic disorders, these data provide support for a possible role of prenatal exposure to DDE in programming these health problems. Future research is needed to assess whether the association may be causal and what the underlying mechanisms might be.

Supplemental Material is available online (doi:10.1289/ehp.1002169 via <http://dx.doi.org/>).
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###### 

Characteristics of rapid, average, and slow growers.

  Characteristic                                                          Average/slow growers (*n* = 393)   Rapid growers (*n* = 125)   *p*-Value[a](#tfn2-ehp-119-272){ref-type="table-fn"}
  ----------------------------------------------------------------------- ---------------------------------- --------------------------- ------------------------------------------------------
  Male sex                                                                201 (51.2)                         64 (51.2%)                  0.991
                                                                                                                                         
  Birth characteristics                                                                                                                  
                                                                                                                                         
   Birth weight (kg)                                                      3.34 ± 0.02                        3.04 ± 0.04                 \< 0.001
   Birth weight *z*-score                                                 0.069 ± 0.039                      −0.574 ± 0.076              \< 0.001
   Birth length (cm)                                                      49.69 ± 0.09                       48.98 ± 0.16                \< 0.001
   Gestational age (weeks)                                                39.90 ± 0.06                       39.53 ± 0.10                0.003
   SGA                                                                    17 (4.34)                          21 (16.80)                  \< 0.001
   Low birth weight (\< 2,500 g)                                          3 (0.76)                           12 (9.60)                   \< 0.001
                                                                                                                                         
  Infant growth at 6 and 14 months                                                                                                       
                                                                                                                                         
   Weight at 6 months (kg)                                                7.42 ± 0.04                        8.29 ± 0.08                 \< 0.001
   Weight *z*-score at 6 months                                           −0.28 ± 0.80                       0.68 ± 0.83                 \< 0.001
   Weight at 14 months (kg)                                               10.07 ± 0.05                       11.12 ± 0.12                \< 0.001
   Length at 14 months (cm)                                               77.37 ± 0.15                       78.75 ± 0.24                \< 0.001
   BMI at 14 months (kg/m^2^)                                             16.64 ± 1.33                       18.26 ± 1.51                \< 0.001
   Weight *z*-score (14 months)                                           0.12 ± 0.85                        0.96 ± 0.99                 \< 0.001
   Length *z*-score (14 months)                                           −0.20 ± 1.04                       0.33 ± 0.96                 \< 0.001
   BMI *z*-score (14 months)                                              0.34 ± 0.82                        1.06 ± 0.95                 \< 0.001
                                                                                                                                         
  Parental characteristics                                                                                                               
                                                                                                                                         
   Maternal age (years)                                                   31.78 ± 0.21                       31.63 ± 0.41                0.983
   Maternal height (m)                                                    1.62 ± 0.00                        1.63 ± 0.01                 0.592
   Maternal parity (firstborn)                                            216 (54.96)                        76 (60.80)                  0.252
   Maternal overweight/obesity                                            112 (28.5)                         32 (25.6)                   0.529
   Mother born outside Spain                                              38 (9.74)                          12 (9.76)                   0.997
   Maternal education                                                                                                                    
    Primary or less                                                       94 (23.98)                         42 (33.87)                  
    Secondary                                                             166 (42.35)                        48 (38.71)                  
    University                                                            132 (33.67)                        34 (27.42)                  0.084
   Manual occupation, mother[b](#tfn3-ehp-119-272){ref-type="table-fn"}   181 (46.1)                         66 (52.8)                   0.189
   Paternal height (m)                                                    1.76 ± 0.004                       1.77 ± 0.007                0.257
   Paternal overweight/obesity                                            209 (53.7)                         71 (57.7)                   0.438
   Manual occupation, father                                              206 (56.0)                         73 (61.3)                   0.304

Values are mean ± SD or *n* (%). Data are for the complete analysis data set; missing values for individual covariates ranged from 2 to 14 observations, with *n* = 17 observations lost due to missing values for all covariates combined. There was no significant difference in the proportion missing among average/slow versus rapid growers (*p*-values, two-sample test for proportions \> 0.3). World Health Organization data ([@b10-ehp-119-272]) were used to derive *z*-scores.

*t*-Test (for normally distributed) or Wilcoxon--Mann--Whitney for continuous variables; chi-square test for categorical variables.

Manual occupation: skilled or partially skilled manual workers during pregnancy or most recent job before pregnancy.

###### 

Lipid-adjusted OC levels in first-trimester maternal serum for rapid and average/slow growers \[geometric mean (95% (CI)\].

  OC                                                  Percent \< LOD[a](#tfn5-ehp-119-272){ref-type="table-fn"}   Average/slow growers      Rapid growers
  --------------------------------------------------- ----------------------------------------------------------- ------------------------- -------------------------
  All infants, ng/g lipid (*n* = 518)                                                                                                       
                                                                                                                                            
   DDE                                                0.0                                                         125.40 (115.03--136.70)   135.59 (119.48--153.87)
   HCB                                                8.5                                                         23.38 (19.00--28.78)      26.53 (18.47--38.13)
   βHCH                                               10.0                                                        17.79 (14.37--22.04)      20.46 (13.98--29.94)
   [∑](#tfn4-ehp-119-272){ref-type="table-fn"}PCBs    7.7                                                         43.72 (36.36--52.56)      47.99 (34.84--66.11)
                                                                                                                                            
  Normal-weight mothers, ng/g lipid (*n* = 374)                                                                                             
                                                                                                                                            
   DDE[\*](#tfn6-ehp-119-272){ref-type="table-fn"}    0.0                                                         120.76 (108.70--134.15)   146.78 (127.97--168.35)
   HCB[\*](#tfn6-ehp-119-272){ref-type="table-fn"}    9.1                                                         18.82 (14.51--24.42)      31.21 (21.89--44.50)
   βHCH[\*](#tfn6-ehp-119-272){ref-type="table-fn"}   10.4                                                        15.09 (11.57--19.70)      25.54 (17.55--37.19)
   [∑](#tfn4-ehp-119-272){ref-type="table-fn"}PCBs    7.2                                                         45.20 (36.02--56.73)      66.96 (51.20--87.58)
                                                                                                                                            
  Overweight mothers, ng/g lipid (*n* = 144)                                                                                                
                                                                                                                                            
   DDE                                                0.0                                                         137.84 (118.71--160.07)   107.68 (80.46--144.10)
   HCB                                                6.9                                                         40.28 (29.64--54.74)      16.56 (6.11--44.89)
   βHCH                                               9.0                                                         26.89 (19.20--37.66)      10.73 (3.85--29.86)
   [∑](#tfn4-ehp-119-272){ref-type="table-fn"}PCBs    9.0                                                         40.21 (29.50--54.80)      18.22 (7.14--46.51)

PCBs refers to sum of congeners 118, 138, 153, and 180. Among normal-weight mothers, *n* = 93 rapid growers (24.9%); among overweight mothers, *n* = 32 rapid growers (22.2%). All subjects had detectable levels of DDE.

LOD = 0.071 ng/mL serum for all OCs; values below this level set to LOD/2.

Wilcoxon--Mann--Whitney *p*-value \< 0.05.

###### 

Maternal OC levels and risk of rapid infant weight gain: number of rapid growers in each exposure group.

  OC quartile         Normal-prepregnancy-weight mothers (*n* = 374)   Overweight/obese mothers (*n* = 144)                                                       
  ------------------- ------------------------------------------------ -------------------------------------- ------------------- ----------- ------------------- --------------------
  DDE (ng/g lipid)                                                                                                                                                
                                                                                                                                                                  
   ≤ 71.71            11 (11.7)                                        1.00                                   1.00                14 (38.9)   1.00                1.00
   71.71--116.92      27 (28.7)                                        2.42 (1.25--4.67)                      2.21 (1.14--4.29)   5 (14.3)    0.48 (0.19--1.23)   0.61 (0.22--1.69)
   116.92--186.17     27 (29.3)                                        2.47 (1.24--4.92)                      2.21 (1.07--4.54)   8 (21.1)    0.66 (0.29--1.54)   0.87 (0.41--1.87)
   \> 186.17          28 (29.8)                                        2.47 (1.22--5.00)                      2.16 (1.05--4.45)   5 (14.3)    0.43 (0.18--1.06)   0.43 (0.15--1.24)
                                                                                                                                                                  
  HCB (ng/g lipid)                                                                                                                                                
                                                                                                                                                                  
   ≤ 22.84            20 (18.0)                                        1.00                                   1.00                8 (42.1)    1.00                1.00
   22.84--41.00       20 (21.7)                                        1.17 (0.66--2.08)                      0.92 (0.50--1.69)   10 (27.0)   0.46 (0.21--0.99)   0.17 (0.07--0.45)
   41.00--66.28       26 (28.0)                                        1.54 (0.90--2.64)                      1.14 (0.60--2.17)   5 (13.5)    0.21 (0.08--0.52)   0.10 (0.03--0.35)
   \> 66.28           27 (34.6)                                        1.78 (0.96--3.32)                      1.20 (0.56--2.56)   9 (17.6)    0.19 (0.07--0.57)   0.11 (0.03--0.51)
                                                                                                                                                                  
  βHCH (ng/g lipid)                                                                                                                                               
                                                                                                                                                                  
   ≤ 21.70            16 (15.8)                                        1.00                                   1.00                8 (27.6)    1.00                1.00
   21.70--32.23       25 (25.0)                                        1.67 (0.95--2.93)                      1.45 (0.81--2.62)   10 (34.5)   1.19 (0.48--2.96)   3.88 (1.40--10.70)
   32.23--47.28       22 (24.7)                                        1.53 (0.83--2.85)                      1.13 (0.54--2.36)   6 (14.6)    0.44 (0.16--1.18)   1.95 (0.60--6.36)
   \> 47.28           30 (35.7)                                        2.08 (1.11--3.87)                      1.42 (0.67--3.01)   8 (17.8)    0.52 (0.16--1.67)   2.02 (0.63--6.48)

Multivariable model adjusted for exact age at examination, gestational age, any breast-feeding at 6 months, firstborn child, maternal smoking during pregnancy, education, and maternal age at delivery.

Additionally adjusted for quartiles of the other two OCs shown.

###### 

Associations for rapid early growth, maternal OC levels, and elevated BMI *z*-score (≥ 1.44) at 14 months \[RR (95% CI)\].

  Variable                              All mothers (*n* = 502)   Normal-prepregnancy-weight mothers (*n* = 365)   Overweight/obese mothers (*n* = 137)   Interaction *p*-value (× maternal weight status)
  ------------------------------------- ------------------------- ------------------------------------------------ -------------------------------------- --------------------------------------------------
  Multivariable models                                                                                                                                    
                                                                                                                                                          
   DDE (per log ng/g lipid)             1.22 (0.96--1.55)         1.64 (1.24--2.18)                                0.93 (0.60--1.45)                      0.086
   HCB (per log ng/g lipid)             0.97 (0.86--1.10)         1.02 (0.88--1.18)                                0.74 (0.63--0.87)                      0.680
   βHCH (per log ng/g lipid)            1.03 (0.93--1.15)         1.06 (0.90--1.23)                                0.97 (0.84--1.12)                      0.678
   Rapid growth in the first 6 months   4.71 (3.02--7.35)         5.18 (2.92--9.18)                                5.02 (2.56--9.85)                      0.420
                                                                                                                                                          
  Mutually adjusted contaminants                                                                                                                          
                                                                                                                                                          
   DDE (per log ng/g lipid)             1.40 (1.12--1.75)         1.50 (1.11--2.03)                                1.22 (0.81--1.84)                      0.270
   HCB (per log ng/g lipid)             1.00 (0.85--1.17)         0.99 (0.85--1.15)                                0.91 (0.74--1.12)                      0.340
   βHCH (per log ng/g lipid)            0.96 (0.81--1.12)         0.92 (0.78--1.09)                                0.95 (0.76--1.18)                      0.601
   Rapid growth in the first 6 months   4.85 (3.12--7.54)         5.41 (2.88--10.15)                               4.40 (2.09--9.28)                      0.592

Data are multivariable-adjusted RRs (95% CIs) for likelihood of having an elevated BMI *z*-score at 14 months. All models adjusted for exact age at examination, maternal country of birth, maternal age at delivery, smoking during pregnancy, and parental overweight; rapid growth was included in all models along with either individual or multiple contaminants, as indicated.
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